These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 6139671)

  • 1. Cyproterone acetate in treatment of post-orchidectomy hot flushes. Double-blind cross-over trial.
    Eaton AC; McGuire N
    Lancet; 1983 Dec; 2(8363):1336-7. PubMed ID: 6139671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyproterone and post-orchidectomy flushes.
    Magill PJ; Stonier PD
    Lancet; 1984 Jan; 1(8369):161. PubMed ID: 6140463
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyproterone acetate for treatment of hot flashes after orchiectomy.
    Moon TD
    J Urol; 1985 Jul; 134(1):155-6. PubMed ID: 3159912
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: a double-blind, randomised trial.
    Irani J; Salomon L; Oba R; Bouchard P; Mottet N
    Lancet Oncol; 2010 Feb; 11(2):147-54. PubMed ID: 19963436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cyproterone acetate in the treatment of post-orchiectomy flushing].
    Jansen JE; Hendriksen ON
    Ugeskr Laeger; 1989 Feb; 151(9):560-1. PubMed ID: 2522257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyproterone acetate in the management of prostatic cancer.
    Tunn UW
    Prog Clin Biol Res; 1989; 303():105-10. PubMed ID: 2528734
    [No Abstract]   [Full Text] [Related]  

  • 7. alpha-Methyldopa for climacteric hot flushes. A double-blind, randomized, cross-over study.
    Andersen O; Engebretsen T; Solberg VM; Orbo A
    Acta Obstet Gynecol Scand; 1986; 65(5):405-9. PubMed ID: 3535358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EORTC protocol 30761: a randomized study of non-metastatic and metastatic prostatic cancer treated by cyproterone acetate versus diethylstilbestrol and medroxyprogesterone acetate. European Organization for Research on Treatment of Cancer Urological Group.
    Pavone-Macaluso M; Schröder FH; de Voogt HJ; Viggiano G; Barasolo E; Lardennois B; de Pauw M; Sylvester R; Smith PH; Suciu S
    Prog Clin Biol Res; 1989; 303():111-6. PubMed ID: 2528735
    [No Abstract]   [Full Text] [Related]  

  • 9. Use of cyproterone acetate in prostate cancer.
    Goldenberg SL; Bruchovsky N
    Urol Clin North Am; 1991 Feb; 18(1):111-22. PubMed ID: 1825143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The position of cyproterone acetate (CPA), a steroidal anti-androgen, in the treatment of prostate cancer.
    de Voogt HJ
    Prostate Suppl; 1992; 4():91-5. PubMed ID: 1533452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of vasomotor syndrome in the treatment of advanced prostatic cancer: apropos of 37 cases].
    Ronzoni G; De Giovanni L; Menchinelli P; Meneschincheri M
    Arch Ital Urol Androl; 1998 Feb; 70(1):37-40. PubMed ID: 9549167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orchiectomy combined with cyproterone acetate or prednisone in the treatment of advanced prostatic carcinoma. A randomized clinical and endocrine study.
    Sander S; Nissen-Meyer R; Aakvaag A
    Scand J Urol Nephrol; 1982; 16(3):193-7. PubMed ID: 6219455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestogens: therapeutic and adverse effects in early post-menopausal women.
    Marslew U; Riis B; Christiansen C
    Maturitas; 1991 Mar; 13(1):7-16. PubMed ID: 1830636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hot flushes: mechanism and prevention.
    Radlmaier A; Bormacher K; Neumann F
    Prog Clin Biol Res; 1990; 359():131-40; discussion 141-53. PubMed ID: 2149457
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cyproterone acetate and cancer of the prostate. Experience in 46 cases].
    Tauveron I; Hermabessière J
    Therapie; 1988 May; 43(3):175-7. PubMed ID: 2971277
    [No Abstract]   [Full Text] [Related]  

  • 16. Complete androgen blockade: the EORTC experience comparing orchidectomy versus orchidectomy plus cyproterone acetate versus low-dose stilboestrol in the treatment of metastatic carcinoma of the prostate.
    Robinson MR
    Prog Clin Biol Res; 1987; 243A():383-90. PubMed ID: 2958863
    [No Abstract]   [Full Text] [Related]  

  • 17. Bleeding patterns during continuous combined estrogen-progestogen therapy.
    Marslew U; Riis BJ; Christiansen C
    Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1163-8. PubMed ID: 1827947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acne: double blind clinical and laboratory trial of tetracycline, oestrogen-cyproterone acetate, and combined treatment.
    Greenwood R; Brummitt L; Burke B; Cunliffe WJ
    Br Med J (Clin Res Ed); 1985 Nov; 291(6504):1231-5. PubMed ID: 2933119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Short-term anti-androgen therapy and very long-acting depot gonadotrophin-releasing hormone agonist for prostatic cancer.
    Waxman J
    Prog Clin Biol Res; 1989; 303():61-8. PubMed ID: 2528741
    [No Abstract]   [Full Text] [Related]  

  • 20. EORTC protocol 30805: a phase III trial comparing orchidectomy versus orchidectomy and cyproterone acetate and low dose stilboestrol in the management of metastatic carcinoma of the prostate.
    Robinson MR
    Prog Clin Biol Res; 1988; 260():101-10. PubMed ID: 2966402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.